RT Journal Article
SR Electronic
T1 Fifty-one novel, replicated loci identified in genome-wide association study of polyunsaturated and monounsaturated fatty acids in 124,024 European individuals
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.05.27.22275343
DO 10.1101/2022.05.27.22275343
A1 Francis, Michael
A1 Sun, Yitang
A1 Xu, Huifang
A1 Brenna, J. Thomas
A1 Ye, Kaixiong
YR 2022
UL http://medrxiv.org/content/early/2022/05/31/2022.05.27.22275343.abstract
AB Circulating polyunsaturated and monounsaturated fatty acid (PUFA and MUFA) levels, whose imbalances co-occur with human metabolic diseases, have strong heritable components. We performed the largest genome-wide association study (GWAS) to-date on fourteen PUFA and MUFA phenotypes, measured by nuclear magnetic resonance in plasma. We identified 612 significant loci-phenotype associations (115 unique loci; P < 1.678*10−8) in a European cohort from UK Biobank (UKB-EUR; n=101,729). Replication of five phenotypes (omega-3, omega-6, DHA, LA, MUFAs) was conducted in two external European studies: FinMetSeq (n=8,751) and a meta-analysis by Kettunnen et al. (n=3,644-13,544). Meta-analysis of these three studies yielded 254 significant loci-phenotype associations (109 unique loci; P < 2.439*10−8); we identified 87 novel loci, 51 of which were replicated. A transcriptome-wide association study of the UKB-EUR cohort revealed an additional twelve novel loci. This study improves our understanding of the genetic architecture of unsaturated fatty acids, and can inform future gene-based dietary interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by the National Institute of General Medical Sciences of the National Institute of Health under award number T32GM007103 (MF) and R35GM143060 (KY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used only openly available human data that were provided by UK Biobank, and publicly available summary statistics from GWAS Catalog.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary statistics are available on GWAS Catalog. All relevant data are included within the manuscript. Additional intermediate data or scripts are available upon request to the authors. https://github.com/michaelofrancis/PUFA_GWAS